Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2008, p. 719-721, Vol. 52, No. 2
0066-4804/08/$08.00+0 doi:10.1128/AAC.01469-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Sequella, Inc., 9610 Medical Center Drive, Suite 200, Rockville, Maryland 20850
Received 13 November 2007/ Returned for modification 17 November 2007/ Accepted 21 November 2007
Translocase I inhibitor compounds derived from capuramycin demonstrated rapid bactericidal activity against several different mycobacterial species. SQ641 was the most active of the compounds, with a MIC of 0.12 to 8 µg/ml, a postantibiotic effect of 55 h, and interesting synergistic effects with other antitubercular drugs.
Published ahead of print on 10 December 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»